Screener
Co-Diagnostics, Inc. CODX Q3 2025 earnings
Reported November 13, 2025 · After market close
Revenue$145.4KBeat by $19.4K
EPS-$4.80Beat by $0.91
Revenue estimate$126.0K
EPS estimate-$5.71
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$169.0K
EPS estimate-$1.25
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Co-Diagnostics, Inc. report Q3 2025 earnings?
- Co-Diagnostics, Inc. (CODX) reported Q3 2025 earnings on November 13, 2025 after market close.
- What were Co-Diagnostics, Inc.'s Q3 2025 revenue and EPS?
- Co-Diagnostics, Inc. reported revenue of $145.4K and eps of $-4.80 for Q3 2025.
- Did Co-Diagnostics, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $126.0K by $19.4K. EPS beat the consensus estimate of $-5.71 by $0.91.
- How did Co-Diagnostics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 77.3% from $641.1K a year earlier and eps declined 1400.0% from $-0.32.
- Where can I find Co-Diagnostics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-25-022283) and the 10-Q periodic report (0001493152-25-022300) directly on SEC EDGAR. The filing index links above go to sec.gov.
